1 / 38

Margaret Herridge MD MPH Professor of Medicine Scientist, Toronto General Research Institute

Long-term Outcomes in Survivors of Complex Critical Illness and their Family Caregivers: Towards RECOVER Phase 1:The RECOVER Program. Margaret Herridge MD MPH Professor of Medicine Scientist, Toronto General Research Institute Interdepartmental Division of Critical Care

ryo
Download Presentation

Margaret Herridge MD MPH Professor of Medicine Scientist, Toronto General Research Institute

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Long-term Outcomes in Survivors of Complex Critical Illness and their Family Caregivers: Towards RECOVER Phase 1:The RECOVER Program Margaret Herridge MD MPH Professor of Medicine Scientist, Toronto General Research Institute Interdepartmental Division of Critical Care University of Toronto, Canadian Critical Care Trials Group

  2. Overview • Spectrum of Disability • Continuum of Weakness • Cognitive Dysfunction and Mood Disorders • RECOVER and risk stratification to optimize rehabilitation

  3. Evidence of diaphragmatic atrophy and increased proteolysis at 18 hours of mechanical ventilation De Jonghe, B. et al. JAMA 2002;288:2859-2867 Ali N et al. AJRCCM 2008; 178:261-268

  4. Herridge et al. N Engl J Med 2003; 348:683-93.

  5. All biopsies were abnormal (6-24 months after ICU discharge) • No patients were exposed to steroids or paralytics • Most common abnormality was type II fiber atrophy • Manifested as narrow angulated fibers; myofibers were reduced to clumps of myonuclei • Myofibrillary disarray on EM • Changes not exclusively attributable to disuse atrophy Angel et al. 2007 Can J Neurol Sci 34: 427-432

  6. Five-Year Outcomes in ARDS Herridge et al. NEJM 2011; 364: 1293-304 Persistent exercise limitation and reduction in Physical QOL at 5-years after ICU discharge

  7. Heterotopic Ossification Alopecia Tracheal stenosis Cosmesis- Scars from CVC, Art line, CT, drain sites Nerve and Muscle Brain Hearing Loss Bronchiectasis Pulmonary fibrosis Taste changes Weakness Mental Health & Cognition frozen joints contractures striae Ischemic digits Disability after Critical Illness Renal Impairment

  8. Hopkins et al. AJRCCM 1999; 160:50 Hopkins et al. J Int Neuropsych Assoc 2003;9:584

  9. Enrolment in a conservative fluid-management strategy was associated with • cognitive impairment • Lower partial pressure of oxygen was associated with cognitive and psychiatric • impairment • Hypoglycemia was associated with mood disorders Am J Respir Crit Care Med 2012; 185:1307-13

  10. Pandharipande et al. NEJM 2013

  11. Sepsis survivors had a reduction in verbal learning and memory • Reduction in left hippocampal volume • Increase in low frequency EEG activity consistent with brain dysfunction • No clinical difference in HRQOL, psychological dysfunction, mood disorders

  12. Ischemic Changes Brain Atrophy Suchyta et al. Brain Imaging and Behavior 4:22-34, 2010

  13. Risk Factors for Cognitive Dysfunction • Duration of Delirium • Blood Glucose Dysregulation • Conservative Fluid Management • Hypoxia • Hypotension • Corticosteroids • Sedatives, Analgesics Mikkelsen et al. AJRCCM 2012; 185:1307-15 Girard et al. Crit Care Med 2010;38: 1513-1520 Hopkins et al. Brain Inj 2010; Sept 21 Epub Hopkins et al. AJRCCM 1999; 160:50-56 Hopkins et al. AJRCCM 2005; 171:340-347 Rothenhausler et al. Gen Hosp Psychiatry 2001; 23: 90-96

  14. Depression • Prevalence 17-43% • May decrease or stay the same over time ( Hopkins 2010; Adhikari 2011) • Risks include: alcohol dependence, female gender, younger age, cognitive dysfunction, hypoglycemia, severity of illness measures, mean ICU benzodiazepine dose • Associated with ability to return to work Davydow et al. Psychosom Med 2008; 70:512-9 Adhikari et al. Chest 2009;135: 678-687 Hopkins et al. Gen Hosp Psychiatry 2010; 32: 147-55 Dowdy et al. Crit Care Med 2009; 37: 1702-7 Dowdy et al. Crit Care Med 2008; 36:2726-33 Douglas et al. J Crit Care 2010; 25: 364 Adhikari et al. Chest 2011; 140: 1484-93

  15. Persecutory Delusions/PTSD Griffiths and Jones BMJ 1999; 319:427-9.

  16. Post Traumatic Stress Disorder • Prevalence 21-35% • Risk factors include benzodiazepine exposure, delusional memory, female sex, younger age, physical restraint in the ICU, low serum cortisol, not receiving corticosteroids, Vent days, ICU LOS • Endogenous personality traits: pessimism Jones et al. Critical Care 2010; 14(5): R168 Myhren et al. Crit Care 2010 ;14: R14 Davydow Crit Care 2010; 14: 125 Kapfhammer et al. Am J Psychiatry 2004; 161: 45-52 Jones, Griffiths et al. Crit Care Med 2001; 29: 573-80 Stoll et al. Int Care Med 1999; 25: 697-704 Schelling et al. Crit Care Med 1998; 26: 651-9

  17. Caregiver Burden CCM 2008; 36: 1722-1728 PTSD symptoms consistent with a moderate to major risk of PTSD were found in 33% of family members. Azoulay et al. AJRCCM 2005; 17: 987-994 Jones et al. Int Care Med 2004; 30: 456-460 Caregiver depression risk was 34%, 31% and 23% at 2, 6, 12 months Lifestyle disruption and employment reduction were common. Compromised HRQOL similar to caregivers of stroke/dementia Depressive symptomatology associated with depression in ARDS survivors . Van Pelt et al. AJRCCM 2007; 175: 167-173 Cameron et al. Crit Care Med 2006;34:26-33

  18. Higher re-experiencing scores on PTSD measures were associated with • higher arousal ratings of negative pictures and reduced amygdala, thalamus • and globuspallidus volumes. • Chronic re-experiencing of traumatic events may result in structural changes • associated with autonomic arousal and acquisition of conditioned fear

  19. Caregiving as a Risk Factor for Mortality:  The Caregiver Health Effects Study JAMA. 1999;282(23):2215-2219

  20. UHN/TRI Lead Canadian Multi-Centre Interprofessional Program of Outcomes and Rehabilitation in Survivors and Family Caregivers after Critical Illness- Program initiated in 2007 • Co-Principal Investigators- Margaret Herridge MD MPH and Jill Cameron PhD

  21. The RECOVER Research Program consists of Four Phases: • Phase II: RECOVER development and pilot testing • Phase III: RECOVER randomized controlled trial • Phase IV: RECOVER KT and Health Policy Change • Phase I: Towards RECOVER

  22. Patient Outcomes (Quantitative) FIM Total Score 6MWT (% of predicted) Total Functional Independence Measure scores at 7-days, 3, 6, and 12-months post ICU discharge Distance walked in 6 minutes (percent of predicted values) at 7-days, 3, 6, and 12-months post ICU discharge 26

  23. Patient Outcomes (Quantitative) SF-36 Physical Component Score MRC Total Score SF-36v2 Physical Component Scores at 3-months, 6-months and 12-months post ICU discharge Total MRC scores at 3-months, 6-months and 12-months post ICU discharge 27

  24. Caregiver Outcomes (Quantitative) Care-giving Impact Scale Centre for Epidemiological Studies Depression Scale Centre for Epidemiological Studies Depression (CESD) at 7 day, 3-months, 6-months and 12-months post ICU discharge Care-giving impact scale at 7 day, 3-months, 6-months and 12-months post ICU discharge ≥16 considered at risk for symptoms of depression 28

  25. Etiologically Neutral Clinical Phenotypes • Different clinical phenotypes for outcome and possibly muscle and nerve correlates for this • Spectrum determined by age, burden of comorbid disease, ICU LOS • Younger group- more intensive rehab, assist with return to work, children • Middle-aged group with comorbidities- Some rehab, OT, planning for ‘new normal’ • Older patients- goals of care, disposition, complex medical management, OT/social work to optimize supports

  26. Challenges and Opportunities • There is a spectrum of disability across clinical phenotypes both in terms of muscle injury/atrophy/dysfunction/ other morbidities and also repair and clinical recovery • We need to understand the basic science correlates of muscle, brain and nerve injury • Different risk groups will require very different interventions and these need to be constructed and tested • The family caregiver needs support and is a key risk modifier of outcome

More Related